Investigating mitochondrial-derived peptides alongside coenzyme dynamics represents a critical frontier in metabolic bioenergetics research. Preclinical models combining MOTS-c with NAD+ signaling agents allow laboratory researchers to interrogate nuclear-mitochondrial communication, AMPK activation, and cellular resilience mechanisms. PX1 Research provides analytical-grade reagents manufactured in the USA to support rigorous, reproducible in vitro and animal assays.
Investigating mitochondrial-derived peptides alongside coenzyme dynamics represents a critical frontier in metabolic bioenergetics research. Preclinical models combining MOTS-c with NAD+ signaling agents allow laboratory researchers to interrogate nuclear-mitochondrial communication, AMPK activation, and cellular resilience mechanisms. PX1 Research provides analytical-grade reagents manufactured in the USA to support rigorous, reproducible in vitro and animal assays.
In cellular bioenergetics, nad peptide research mots-c focuses on evaluating concurrent mitochondrial signal transduction and coenzyme turnover. Preclinical investigations utilize MOTS-c peptide alongside NAD+ modulators to study mitochondrial-derived peptide trans-activation, AMPK phosphorylation, and SIRT1-dependent pathways. These dual-reagent protocols measure metabolic regulation, substrate oxidation, and exercise-capacity mechanisms in cell culture and rodent models.
Mitochondrial-derived peptides (MDPs) like MOTS-c act as retrograde signaling molecules, altering nuclear gene expression in response to bioenergetic stress. When paired with nicotinamide adenine dinucleotide (NAD+) pathways, researchers can monitor how fluctuating intracellular NAD+/NADH ratios influence MDP expression, nuclear translocation, and metabolic homeostatic adaptations.
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA region. Preclinical studies suggest that MOTS-c translocates to the nucleus during metabolic stress, where it interacts with transcription factors such as NRF2 to regulate antioxidant response elements (ARE) and glucose transporters. Concurrently, intracellular NAD+ serves as an essential coenzyme for sirtuins (SIRT1-SIRT7) and PARPs, which govern chromatin remodeling, mitochondrial biogenesis, and DNA repair.
When evaluating mitochondrial research peptides in combination with NAD+ modulators, in vitro data indicate a reciprocal cross-talk. SIRT1 activity relies directly on available NAD+ levels; elevated SIRT1 deacetylates PGC-1α, promoting mitochondrial biogenesis. Parallel signaling via MOTS-c activates AMP-activated protein kinase (AMPK), forming a dual regulatory loop that optimizes cellular ATP production and nutrient sensing under nutrient-depleted experimental conditions.
Laboratory investigations using rodent models have demonstrated that MOTS-c administration influences systemic metabolic regulation and physical performance metrics. In endurance-testing assays, mice treated with MOTS-c exhibited enhanced treadmill performance, altered skeletal muscle substrate utilization, and improved insulin sensitivity in high-fat diet models.
Incorporating NAD+ precursors into these models provides insight into how coenzyme availability alters the magnitude of MOTS-c signaling. Data from NAD+ precursor studies suggest that restoring intracellular NAD+ pools enhances sirtuin-mediated deacetylase activity, which complements the AMPK activation induced by MOTS-c. Researchers measure parameters such as oxygen consumption rates (OCR), extracellular acidification rates (ECAR), and mitochondrial membrane potential (ΔΨm) to map these compound interactions.
To understand the relative potency and signaling pathways of MOTS-c within mitochondrial research, investigators frequently compare it against other targeted metabolic agents. While MOTS-c acts primarily as a retrograde nuclear signal via AMPK, compounds like the SS-31 research compound target cardiolipin within the inner mitochondrial membrane to directly optimize electron transport chain efficiency and reduce reactive oxygen species (ROS).
Additionally, assays exploring Humanin peptide assays provide comparative data on cytoprotection and apoptosis modulation, whereas compounds like the 5-amino-1MQ research compound target NNMT inhibition to elevate intracellular NAD+ levels indirectly. Evaluating these distinct vectors—membrane stabilization, nuclear translocation, and enzymatic inhibition—allows researchers to design robust comparative panels across diverse cell lines.
Reproducibility in metabolic research requires exceptionally pure reagents free from cellular contaminants or synthesis byproducts. PX1 Research synthesizes all compounds in GMP-compliant, ISO 17025-accredited facilities located exclusively in the United States. Every lot undergoes rigorous analytical validation to verify peptide identity, purity, and freedom from endotoxins.
Laboratory researchers can review detailed certificates of analysis (COA) for every batch, which include reversed-phase high-performance liquid chromatography (RP-HPLC) chromatograms and electrospray ionization mass spectrometry (ESI-MS) spectra. PX1 Research ensures endotoxin limits remain strictly below standard in vitro threshold levels (<0.01 EU/μg), protecting delicate cell cultures from lipopolysaccharide-induced inflammatory artifacts.
MOTS-c and NAD+ reagents are delivered as lyophilized cakes or powders to maintain maximum chemical stability during transit. Upon receipt, lyophilized vials should be stored at -20°C or -80°C for long-term preservation. Exposure to ambient room temperature and moisture should be minimized to prevent hydrolysis or aggregation.
For reconstitution, laboratory technicians should use sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the specific cell culture or assay protocol. Reconstitution should be performed under a laminar flow hood using gentle side-wall solvent introduction; mechanical vortexing should be avoided. Once dissolved, aliquot the stock solution into single-use microcentrifuge tubes to prevent degradation from repeated freeze-thaw cycles. Detailed reconstitution matrices are available on the PX1 Research analytical hub.
When designing in vitro assays to examine nad peptide research mots-c synergies, researchers typically evaluate concentration gradients ranging from 10 nM to 10 μM depending on cell type (e.g., C2C12 myotubes, HepG2 hepatocytes, or primary adipocytes). Key end-points include western blot analysis of phosphorylated AMPK (p-AMPK), acetyl-CoA carboxylase (p-ACC), and SIRT1 expression.
In vivo animal models (e.g., C57BL/6J mice) often evaluate metabolic flexibility using indirect calorimetry cages (CLAMS), glucose tolerance tests (GTT), and exercise exhaustion trials. Tissue samples harvested post-assay are analyzed via LC-MS/MS to quantify tissue-specific NAD+/NADH ratios and mitochondrial DNA (mtDNA) to nuclear DNA (nDNA) copy number ratios, providing a comprehensive quantitative picture of mitochondrial biogenesis.
MOTS-c is a short peptide comprising 16 amino acids with the primary sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg. It possesses a molecular weight of approximately 2174.6 g/mol. Due to its cationic nature and hydrophobic residues, careful selection of solvent buffer conditions is critical to maintain solubility at higher stock concentrations.
Understanding structural stability under varying temperature and pH regimes allows researchers to optimize culture media supplementation schedules. Researchers interested in bulk quantities for extended animal studies can explore options through our bulk research peptide procurement program to secure single-lot consistency across large cohort experiments.
Ensuring supply chain integrity is paramount for time-sensitive longitudinal studies. PX1 Research dispatches all domestic orders directly from centralized fulfillment centers in California and Arizona. Orders placed before cut-off times qualify for same-day dispatch Monday through Friday, minimizing transit times and ensuring optimal thermal management.
Institutional accounts, university laboratories, and private research organizations can access our full metabolic peptide catalog with guaranteed lot traceability. Custom synthesis and bulk lyophilization services are tailored to meet exact experimental specifications.
What is the focus of nad peptide research mots-c in laboratory settings?
Research involving NAD+ and MOTS-c focuses on examining dual bioenergetic pathways, specifically how mitochondrial-derived peptide signaling (via AMPK) interacts with sirtuin activation (via NAD+) to regulate mitochondrial biogenesis, substrate oxidation, and cellular stress adaptation.
How does MOTS-c differ from traditional mitochondrial-targeted peptides?
Unlike peptides that act directly inside the inner mitochondrial membrane (such as SS-31), MOTS-c functions as a retrograde messenger that translocates to the nucleus under stress conditions to modulate nuclear gene transcription.
What analytical testing is performed on PX1 Research MOTS-c lots?
Every lot of MOTS-c undergoes RP-HPLC to verify chemical purity (typically >98%) and mass spectrometry (ESI-MS) to confirm exact molecular weight. Endotoxin assays are performed to ensure compliance with strict culture-grade standards.
What solvent should be used to reconstitute MOTS-c for in vitro assays?
MOTS-c is commonly reconstituted using sterile Bacteriostatic Water or sterile PBS (pH 7.4). Avoid aggressive mechanical agitation or vortexing; gentle inversion or side-wall reconstitution is recommended.
How should reconstituted MOTS-c stock solutions be stored?
Reconstituted stock solutions should be aliquoted into single-use vials and stored at -20°C or -80°C to minimize degradation from repeated freeze-thaw cycles. Aliquots are generally stable for up to 30 days at -20°C.
What preclinical evidence exists regarding MOTS-c and exercise capacity?
Rodent studies indicate that MOTS-c administration enhances treadmill performance, promotes skeletal muscle glucose uptake, and increases oxygen consumption rates by upregulating AMPK phosphorylation.
Can MOTS-c be evaluated alongside other metabolic agents like 5-Amino-1MQ?
Yes, researchers frequently combine MOTS-c with 5-Amino-1MQ or NAD+ boosters to study complementary mechanisms—combining NNMT-inhibition-driven NAD+ elevation with MOTS-c retrograde nuclear signaling.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in US-based GMP-compliant facilities and shipped directly from fulfillment centers located in California and Arizona with same-day shipping available Monday through Friday.
Are PX1 Research products intended for human administration?
No. All products supplied by PX1 Research are strictly for laboratory research, in vitro assays, and animal study models. They are not for human or veterinary use, medical diagnosis, or therapeutic applications.
How can high-volume research laboratories obtain bulk lot reservations?
Research laboratories requiring single-lot consistency for large-scale studies can submit a wholesale inquiry through our specialized account portal to reserve dedicated batches with matching COAs.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.